標(biāo)題: Titlebook: Current Approach to Heart Failure; Maria Doroban?u,Frank Ruschitzka,Marco Metra Book 2016 Springer International Publishing Switzerland 20 [打印本頁] 作者: estradiol 時間: 2025-3-21 19:32
書目名稱Current Approach to Heart Failure影響因子(影響力)
書目名稱Current Approach to Heart Failure影響因子(影響力)學(xué)科排名
書目名稱Current Approach to Heart Failure網(wǎng)絡(luò)公開度
書目名稱Current Approach to Heart Failure網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Current Approach to Heart Failure被引頻次
書目名稱Current Approach to Heart Failure被引頻次學(xué)科排名
書目名稱Current Approach to Heart Failure年度引用
書目名稱Current Approach to Heart Failure年度引用學(xué)科排名
書目名稱Current Approach to Heart Failure讀者反饋
書目名稱Current Approach to Heart Failure讀者反饋學(xué)科排名
作者: 專橫 時間: 2025-3-22 00:18
Edmund Pawlowski,Krystian Pawlowskielectrical disease. In the following chapter we will analyze the pathophysiology of dyssynchrony and dyssynchrony assessment, the extent of clinical evidence in cardiac resynchronization therapy and current CRT guidelines, the issue of non-response to CRT, how to improve patient selection and CRT delivery.作者: 鞭子 時間: 2025-3-22 00:38
Edmund Pawlowski,Krystian Pawlowskiilure (HF) treatment. It also reports on the results of the different clinical trials testing these innovative therapeutic approaches and briefly discusses the current needs and future directions of this research field in order to favour its successful translation into the clinical practice.作者: 使?jié)M足 時間: 2025-3-22 08:33 作者: 協(xié)奏曲 時間: 2025-3-22 11:02
http://image.papertrans.cn/d/image/241121.jpg作者: chance 時間: 2025-3-22 13:37
https://doi.org/10.1007/978-3-319-45237-1heart failure; special population; imaging; medical treatment; surgical treatment; device therapy; mechani作者: chance 時間: 2025-3-22 19:14 作者: 評論性 時間: 2025-3-22 23:12 作者: RENIN 時間: 2025-3-23 02:54
https://doi.org/10.1007/978-3-031-56456-7o the low cardiac output is closely linked to the neurohormonal activation and to the renal disturbances which contribute to HF pathophysiology. These multisystem anomalies are in close relationship with local myocardial anomalies represented by alterations of the myocardial extracellular matrix, ab作者: 完成才會征服 時間: 2025-3-23 05:58 作者: Creditee 時間: 2025-3-23 11:25 作者: 混亂生活 時間: 2025-3-23 14:00 作者: Nostalgia 時間: 2025-3-23 20:00 作者: rectocele 時間: 2025-3-23 23:55 作者: left-ventricle 時間: 2025-3-24 03:51
Berna Ulutas,Georgios Ioannou,Stefan Brackeve anatomical, functional and tissue characterization information in one safe and non-irradiating examination. CMR has proven usefulness in all stages of management of heart failure patients (particularly those with reduced ejection fraction), from first diagnosis, establishing etiology and allowing作者: organic-matrix 時間: 2025-3-24 08:53 作者: 滔滔不絕的人 時間: 2025-3-24 12:54
Emma Bagnato,Davide Mauro,Silvana Bagnatochronic heart failure with reduced ejection fraction have completely changed the natural history of this clinical syndrome. The implementation into clinical practice the neurohormonal antagonists (angiotensin converting enzyme inhibitors, beta-blockers, angiotensin receptor antagonists and mineraloc作者: dapper 時間: 2025-3-24 17:13
Emma Bagnato,Davide Mauro,Silvana Bagnatoization in patients with ischemic cardiomyopathy. Few prospective, randomized trials, particularly the STICH trial, have investigated the prognostic role of coronary artery bypass surgery (CABG) on mortality and hospitalization in heart failure. While initial data were not unambiguous, long-term fol作者: 匍匐前進(jìn) 時間: 2025-3-24 20:46
Human Factor in Maintenance Managementle other times a direct cause of haemodynamic deterioration. All arrhythmias may be life-threatening in heart failure patients, directly or through arrhythmia-related complications, magnified by the presence of an underlying structural disease. Patients with heart failure require therefore prompt id作者: Iniquitous 時間: 2025-3-25 01:25
Edmund Pawlowski,Krystian Pawlowskieatening ventricular tachyarrhythmias (ventricular tachycardia, ventricular fibrillation) to a sinus rhythm by means of an antitachycardia pacing and direct biphasic current shock. The implantable cardioverter defibrillators usually have pacemaker function as an additional function.作者: 細(xì)微差別 時間: 2025-3-25 03:41 作者: 小樣他閑聊 時間: 2025-3-25 08:57 作者: Slit-Lamp 時間: 2025-3-25 12:12 作者: 立即 時間: 2025-3-25 18:04
Devices for Heart Failure: Implantable Cardioverter Defibrillatoreatening ventricular tachyarrhythmias (ventricular tachycardia, ventricular fibrillation) to a sinus rhythm by means of an antitachycardia pacing and direct biphasic current shock. The implantable cardioverter defibrillators usually have pacemaker function as an additional function.作者: Parallel 時間: 2025-3-25 21:17 作者: integrated 時間: 2025-3-26 01:27 作者: 幻想 時間: 2025-3-26 07:06
election and mechanism of action of these treatments, whether they be mechanical circulatory devices or pharmacological treatments. The contemporary pharmacological and non-pharmacological management of heart f978-3-319-83247-0978-3-319-45237-1作者: Conduit 時間: 2025-3-26 12:23
Evolving Concepts on the Basic Mechanisms of Heart Failurend intramyocardial signaling. Heart failure with mid-range ejection fraction (HFmEF) is a new term for patients with ejection fraction that ranges from 40 to 49 %, and have characteristics between HFrEF and HFpEF. The new paradigm regarding HFpEF pathophysiology states that this syndrome is the cons作者: Inoperable 時間: 2025-3-26 13:15 作者: 樹木心 時間: 2025-3-26 16:50 作者: 農(nóng)學(xué) 時間: 2025-3-26 22:37 作者: 種類 時間: 2025-3-27 02:43
Book 2016gy that best fits a patient. This book presents detailed information on the indications, selection and mechanism of action of these treatments, whether they be mechanical circulatory devices or pharmacological treatments. The contemporary pharmacological and non-pharmacological management of heart f作者: entitle 時間: 2025-3-27 05:58
https://doi.org/10.1007/978-3-031-56456-7nd intramyocardial signaling. Heart failure with mid-range ejection fraction (HFmEF) is a new term for patients with ejection fraction that ranges from 40 to 49 %, and have characteristics between HFrEF and HFpEF. The new paradigm regarding HFpEF pathophysiology states that this syndrome is the cons作者: POWER 時間: 2025-3-27 09:29 作者: 肉身 時間: 2025-3-27 15:50 作者: 商業(yè)上 時間: 2025-3-27 18:03
Berna Ulutas,Georgios Ioannou,Stefan Bracke cardiomyopathies. Furthermore, late gadolinium enhancement CMR plays an important role in risk stratification of both ischemic and non-ischemic heart failure. Finally, recent clinical data support an emerging role of CMR in guiding device therapy.作者: Gustatory 時間: 2025-3-27 23:07 作者: Deference 時間: 2025-3-28 05:12 作者: originality 時間: 2025-3-28 09:02
Assessment of Left Ventricular Systolic and Diastolic Function by Echocardiography safety profile. It provides a wealth of information about left and right ventricular size, geometry and function, left atrium size, valve function, pulmonary pressures, and the pericardium. It provides evidence about the cause of HF, which is critical for the selection of the best treatment. The as作者: foreign 時間: 2025-3-28 10:46
The Imaging of Right Ventricular Dysfunction in Heart Failurevasive assessment of the RV is a challenging task due to its complex anatomy and location in the chest.Moreover, the high load dependency of RV function can also lead to inaccurate or misleading interpretation of intrinsic RV function parameters if they are taken in isolation form RV pre- and afterl作者: lobster 時間: 2025-3-28 18:19 作者: 賠償 時間: 2025-3-28 21:50 作者: EXALT 時間: 2025-3-29 00:44
Left Ventricular Contactile ReserveGlobal contractility indices will be discussed starting from ventricular and arterial elastance and their clinical application. Integrating left ventricular ejection fraction into the concept of ventriculo-arterial coupling, provides a more comprehensive approach of the relationship preload-contract作者: JIBE 時間: 2025-3-29 06:18
Role of Cardiovascular Magnetic Resonance Imaging in Heart Failureve anatomical, functional and tissue characterization information in one safe and non-irradiating examination. CMR has proven usefulness in all stages of management of heart failure patients (particularly those with reduced ejection fraction), from first diagnosis, establishing etiology and allowing作者: 破裂 時間: 2025-3-29 09:08
The Evolving Role of Multimodality Imaging in Heart Failure myocardial viability, coronary anatomy and regional relative or absolute myocardial perfusion..The different modalities may be performed separately and integrated/fused afterwards (i.e. through hybrid imaging) or may be used in a single step approach to define HF etiology, the extent and severity o作者: 易碎 時間: 2025-3-29 12:40
Contemporary Pharmacological Treatment of Heart Failurechronic heart failure with reduced ejection fraction have completely changed the natural history of this clinical syndrome. The implementation into clinical practice the neurohormonal antagonists (angiotensin converting enzyme inhibitors, beta-blockers, angiotensin receptor antagonists and mineraloc作者: cinder 時間: 2025-3-29 17:04
Myocardial Revascularization in Heart Failureization in patients with ischemic cardiomyopathy. Few prospective, randomized trials, particularly the STICH trial, have investigated the prognostic role of coronary artery bypass surgery (CABG) on mortality and hospitalization in heart failure. While initial data were not unambiguous, long-term fol作者: 聽覺 時間: 2025-3-29 21:10 作者: 灰姑娘 時間: 2025-3-30 01:24 作者: PANT 時間: 2025-3-30 05:25
Cardiac Resynchronization Therapyelectrical disease. In the following chapter we will analyze the pathophysiology of dyssynchrony and dyssynchrony assessment, the extent of clinical evidence in cardiac resynchronization therapy and current CRT guidelines, the issue of non-response to CRT, how to improve patient selection and CRT de作者: 有罪 時間: 2025-3-30 09:46
Mechanical Circulatory Support, the majority of these patients do not survive. Recent improvements in technology have allowed development of durable ventricular assist devices that can support an increasing number of patients for longer duration of time while allowing restoration of fairly normal quality of life. Over the past d作者: INERT 時間: 2025-3-30 15:17
Gene and Cell Therapy in Heart Failureilure (HF) treatment. It also reports on the results of the different clinical trials testing these innovative therapeutic approaches and briefly discusses the current needs and future directions of this research field in order to favour its successful translation into the clinical practice.作者: fledged 時間: 2025-3-30 18:20 作者: CHOIR 時間: 2025-3-30 22:13
Assessment of Secondary Mitral Regurgitation, in particular, echocardiography, plays a critical role for the initial and longitudinal assessment, for individual risk stratification and outcome prediction, and for guiding intervention in patients with chronic SMR.作者: 薄膜 時間: 2025-3-31 04:48
Oleg Krol,Vladimir Sokolov,Oleksandr Logunovion-afterload and an easier diagnosis of the afterload mismatch, which is a key knowledge for dynamic tests in heart failure. Longitudinal contraction assessment, by DTI or strain, is discussed for its powerful predictability.作者: artless 時間: 2025-3-31 08:13
Oleg Krol,Vladimir Sokolov,Oleksandr Logunovf myocardial damage/ischemia, indicate and predict the response to targeted treatments (i.e. CRT, coronary revascularization) as well as to perform pre-interventional assessment (i.e. to program trans-catheter ablation of arrhythmias or valvular interventions)作者: MEN 時間: 2025-3-31 11:16
Andrea Bonci,Dorota Stadnicka,Sauro Longhi the age of 55 years and about 20 % at the age of 40 years. The prevalence of HF is approximately 1–2 % of the adult population, rising to more than 10 % among people over 70 years of age. Recent reports show a substantial decline in HF incidence, particularly for HF with reduced ejection fraction, but no apparent change in mortality.作者: AND 時間: 2025-3-31 13:23
Emma Bagnato,Davide Mauro,Silvana Bagnatorug classes: If- channel inhibitor and angiotensin receptor neprilysin inhibitor, have been found to further improve the outcomes of these patients. Nowadays by applying all evidence-based discoveries for heart failure management, it is becoming preventable and treatable disease.作者: output 時間: 2025-3-31 18:31
